Responses
Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013
179
EFFICACY AND SAFETY OF NATALIZUMAB TREATMENT FOR RELAPSING–REMITTING MULTIPLE SCLEROSIS: INTERIM RESULTS OF THE TYSABRI® OBSERVATIONAL PROGRAMME IN THE UK
Compose a Response to This Article
Other responses
No responses have been published for this article.